Morgan Stanley’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.63K | Hold |
31,069
| – | – | ﹤0.01% | 6867 |
|
|
2025
Q1 | $13.1K | Buy |
31,069
+14,196
| +84% | +$5.97K | ﹤0.01% | 6723 |
|
|
2024
Q4 | $11.8K | Buy |
16,873
+15,873
| +1,587% | +$11.1K | ﹤0.01% | 6744 |
|
|
2024
Q3 | $469 | Sell |
1,000
-2,000
| -67% | -$938 | ﹤0.01% | 7307 |
|
|
2024
Q2 | $4.98K | Hold |
3,000
| – | – | ﹤0.01% | 6852 |
|
|
2024
Q1 | $5.46K | Sell |
3,000
-40,738
| -93% | -$74.1K | ﹤0.01% | 6871 |
|
|
2023
Q4 | $80.9K | Buy |
43,738
+21,869
| +100% | +$40.5K | ﹤0.01% | 6229 |
|
|
2023
Q3 | $31.5K | Hold |
21,869
| – | – | ﹤0.01% | 6334 |
|
|
2023
Q2 | $40K | Hold |
21,869
| – | – | ﹤0.01% | 6307 |
|
|
2023
Q1 | $43.3K | Hold |
21,869
| – | – | ﹤0.01% | 6334 |
|
|
2022
Q4 | $45.9K | Hold |
21,869
| – | – | ﹤0.01% | 6332 |
|
|
2022
Q3 | $42K | Hold |
21,869
| – | – | ﹤0.01% | 6475 |
|
|
2022
Q2 | $46K | Buy |
+21,869
| New | +$46K | ﹤0.01% | 6648 |
|